Israel’s MeMed (reported here previously) has received clearance in Israel, Europe and Switzerland for its MeMed BV and MeMed Key infection analyzers. They measure 3 biomarker proteins and use AI algorithms to determine if an infection is viral or bacterial and whether to use antibiotics.

https://www.calcalistech.com/ctech/articles/0,7340,L-3865516,00.html